Gene and cell therapy for pancreatic cancer
INTRODUCTION: The clinical outcomes of patients with pancreatic cancer are poor, and the limited success of classical chemotherapy underscores the need for new, targeted approaches for this disease. The delivery of genetic material to cells allows for a variety of therapeutic concepts. Engineered ag...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 Jan 2015
|
| In: |
Expert opinion on biological therapy
Year: 2015, Volume: 15, Issue: 4, Pages: 505-516 |
| ISSN: | 1744-7682 |
| Online Access: |
|
| Author Notes: | Hans Martin Singh, MD, Guy Ungerechts, MD PhD, and Apostolia M. Tsimberidou, MD PhD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 156173473X | ||
| 003 | DE-627 | ||
| 005 | 20230427122024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170804s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1517/14712598.2015.1001734 |2 doi | |
| 035 | |a (DE-627)156173473X | ||
| 035 | |a (DE-576)491734735 | ||
| 035 | |a (DE-599)BSZ491734735 | ||
| 035 | |a (OCoLC)1340978194 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Singh, Hans Martin |d 1986- |e VerfasserIn |0 (DE-588)1077055021 |0 (DE-627)835896986 |0 (DE-576)445904542 |4 aut | |
| 245 | 1 | 0 | |a Gene and cell therapy for pancreatic cancer |c Hans Martin Singh, MD, Guy Ungerechts, MD PhD, and Apostolia M. Tsimberidou, MD PhD |
| 264 | 1 | |c 13 Jan 2015 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.08.2017 | ||
| 520 | |a INTRODUCTION: The clinical outcomes of patients with pancreatic cancer are poor, and the limited success of classical chemotherapy underscores the need for new, targeted approaches for this disease. The delivery of genetic material to cells allows for a variety of therapeutic concepts. Engineered agents based on synthetic biology are under clinical investigation in various cancers, including pancreatic cancer. AREAS COVERED: This review focuses on Phase I - III clinical trials of gene and cell therapy for pancreatic cancer and on future implications of recent translational research. Trials available in the US National Library of Medicine (www.clinicaltrials.gov) until February 2014 were reviewed and relevant published results of preclinical and clinical studies were retrieved from www.pubmed.gov . EXPERT OPINION: In pancreatic cancer, gene and cell therapies are feasible and may have synergistic antitumor activity with standard treatment and/or immunotherapy. Challenges are related to application safety, manufacturing costs, and a new spectrum of adverse events. Further studies are needed to evaluate available agents in carefully designed protocols and combination regimens. Enabling personalized cancer therapy, insights from molecular diagnostic technologies will guide the development and selection of new gene-based drugs. The evolving preclinical and clinical data on gene-based therapies can lay the foundation for future avenues improving patient care in pancreatic cancer. | ||
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Cell- and Tissue-Based Therapy | |
| 650 | 4 | |a cell engineering | |
| 650 | 4 | |a Clinical Trials as Topic | |
| 650 | 4 | |a Genetic Therapy | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a investigational | |
| 650 | 4 | |a oncolytic virotherapy | |
| 650 | 4 | |a pancreatic cancer | |
| 650 | 4 | |a Pancreatic Neoplasms | |
| 700 | 1 | |a Ungerechts, Guy |d 1972- |e VerfasserIn |0 (DE-588)124557902 |0 (DE-627)363420053 |0 (DE-576)294230939 |4 aut | |
| 700 | 1 | |a Tsimberidou, Apostolia M. |e VerfasserIn |0 (DE-588)1137733985 |0 (DE-627)895096390 |0 (DE-576)491734638 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on biological therapy |d Abingdon : Taylor & Francis Group, 2001 |g 15(2015), 4, Seite 505-516 |h Online-Ressource |w (DE-627)355985446 |w (DE-600)2091082-4 |w (DE-576)302969578 |x 1744-7682 |7 nnas |a Gene and cell therapy for pancreatic cancer |
| 773 | 1 | 8 | |g volume:15 |g year:2015 |g number:4 |g pages:505-516 |g extent:12 |a Gene and cell therapy for pancreatic cancer |
| 951 | |a AR | ||
| 992 | |a 20170804 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 124557902 |a Ungerechts, Guy |m 124557902:Ungerechts, Guy |d 910000 |d 910100 |e 910000PU124557902 |e 910100PU124557902 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1077055021 |a Singh, Hans Martin |m 1077055021:Singh, Hans Martin |d 910000 |d 910100 |e 910000PS1077055021 |e 910100PS1077055021 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN156173473X |e 2976301107 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.08.2017"],"recId":"156173473X","language":["eng"],"title":[{"title_sort":"Gene and cell therapy for pancreatic cancer","title":"Gene and cell therapy for pancreatic cancer"}],"person":[{"role":"aut","display":"Singh, Hans Martin","roleDisplay":"VerfasserIn","given":"Hans Martin","family":"Singh"},{"given":"Guy","family":"Ungerechts","role":"aut","roleDisplay":"VerfasserIn","display":"Ungerechts, Guy"},{"role":"aut","display":"Tsimberidou, Apostolia M.","roleDisplay":"VerfasserIn","given":"Apostolia M.","family":"Tsimberidou"}],"physDesc":[{"extent":"12 S."}],"relHost":[{"id":{"issn":["1744-7682"],"eki":["355985446"],"zdb":["2091082-4"]},"origin":[{"publisherPlace":"Abingdon ; London ; London","dateIssuedKey":"2001","publisher":"Taylor & Francis Group ; Ashley ; Informa Healthcare","dateIssuedDisp":"2001-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Expert opinion on biological therapy","title":"Expert opinion on biological therapy"}],"part":{"extent":"12","text":"15(2015), 4, Seite 505-516","volume":"15","pages":"505-516","issue":"4","year":"2015"},"pubHistory":["1.2001 -"],"recId":"355985446","language":["eng"],"note":["Gesehen am 08.09.15"],"disp":"Gene and cell therapy for pancreatic cancerExpert opinion on biological therapy","type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"13 Jan 2015"}],"id":{"doi":["10.1517/14712598.2015.1001734"],"eki":["156173473X"]},"name":{"displayForm":["Hans Martin Singh, MD, Guy Ungerechts, MD PhD, and Apostolia M. Tsimberidou, MD PhD"]}} | ||
| SRT | |a SINGHHANSMGENEANDCEL1320 | ||